SCHEMBL4631199

SCHEMBL4631199

C[C@@H](c1ccccc1)C1CNCCO1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 15/20 0.57
SLC6A4 P31645 15/20 0.57
SLC6A3 Q01959 11/20 0.57
MLNR O43193 1/20 0.53
ADRB2 P07550 1/20 0.53
CHRM2 P08172 1/20 0.53
CHRM1 P11229 1/20 0.53
CHRM3 P20309 1/20 0.53
HTR2C P28335 1/20 0.53
OPRK1 P41145 1/20 0.53
KCNH2 Q12809 1/20 0.53
KDM4E B2RXH2 1/20 0.53
MEN1 O00255 1/20 0.53
ALDH1A1 P00352 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C9 P11712 1/20 0.53
MAPK1 P28482 1/20 0.53
KMT2A Q03164 1/20 0.53
HRH1 P35367 3/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1961849 1.00 SLC6A2 (0.57) SLC6A2SLC6A4SLC6A3MLNRADRB2
SCHEMBL6540781 0.86 SLC6A2 (0.56) SLC6A2SLC6A4SLC6A3MLNRADRB2
SCHEMBL28775877 0.85 SLC6A2 (0.56) SLC6A2SLC6A4SLC6A3MLNRADRB2
SCHEMBL6978722 0.84 SLC6A2 (0.42) SLC6A2SLC6A4SLC6A3MLNRADRB2
SCHEMBL27790028 0.84 SLC6A2 (0.42) SLC6A2SLC6A4SLC6A3MLNRADRB2
SCHEMBL27989307 0.81 SLC6A2 (0.49) SLC6A2SLC6A4SLC6A3MLNRADRB2
SCHEMBL28352387 0.81 SLC6A2 (0.52) SLC6A2SLC6A4SLC6A3MLNRADRB2
SCHEMBL27781287 0.80 SLC6A2 (0.40) SLC6A2SLC6A4SLC6A3MLNRADRB2
SCHEMBL4595727 0.80 SLC6A2 (0.53) SLC6A2SLC6A4SLC6A3MLNRADRB2
SCHEMBL4596454 0.80 SLC6A2 (0.53) SLC6A2SLC6A4SLC6A3MLNRADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910320-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2008-04-16 EP disclosed
WO-2007011065-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2007-01-25 WO disclosed